Myriad Genetics, Inc.

Company Details:

Company Symbol: MYGN
Sector: Healthcare & Medical Devices
Company Rating: buy
URL: www.myriad.com

Related Research

  • 05/02/12 Morning Note B. Riley & Co. Morning Notes: BEBE, EGHT, EXAR, EXAS, FEIC, HOTT, KEYN, KSWS, MYGN, OPLK, PII, PRGX, RBCN, RGC, SIMG, WWWW
  • 05/02/12 Desk Report MYGN (Buy; $35.00 PT): A master class in management execution leads to Q3 beat on top and bottom line; Management increases FY’12 guidance; Increasing…
  • 04/30/12 Morning Note B. Riley & Co. Morning Notes: ANH, CALD, CELL, CinemaCon Recap, Exhibitors and Related Technology, CLNY, FCAL, KEYN, MYGN, PPC, PRGX, Q1 '12 Earnings…
  • 04/03/12 Morning Note B. Riley & Co. Morning Notes: AEO, AXTI, BC, CLNY, CREE, DRL, EVOL, FCAL, GSM, JMBA, KONA, KTOS, LIOX, MSPD, MYGN, TIVO, WWWW
  • 04/03/12 Update B. Riley & Co. Focus List for the Month of April: AEO, AXTI, BC, CLNY, DRL, GSM, JMBA, KTOS, LIOX, MSPD, MYGN, TIVO, WWWW
  • 03/21/12 Morning Note B. Riley & Co. Morning Notes: DSW, HAFC, IMAX, KKD, MYGN
  • 03/01/12 Morning Note B. Riley & Co. Morning Notes: ACW, AXTI, BC, CKEC, DRL, EWBC, FNSR, GPX, GSM, HOTT, JMBA, KTOS, LIOX, MSPD, MYGN, PPC, TWO, WWWW, ZUMZ
  • 03/01/12 Update B. Riley & Co Focus List for the Month of March: AXTI, BC, CKEC, DRL, GSM, HOTT, JMBA, KTOS, LIOX, MSPD, MYGN, TWO, WWWW
  • 02/01/12 Morning Note B. Riley & Co. Morning Notes: AFOP, AKAM, AOL, AXTI, BC, BEBE, CAMP, CSTR, DRL, EHTH, GSM, HOTT, IMAX, JDSU, JMBA, KEYN, KCP, KTOS, LIOX, MSPD, MYGN,…
  • 02/01/12 Update B. Riley & Co Focus List for the Month of January: AXTI, BC, CSTR, DRL, GSM, HOTT, JMBA, KTOS, LIOX, MSPD, MYGN, TWO, WWWW
  • 02/01/12 Update MYGN (Buy; $32.00): Strong execution on key growth initiatives leads to Q2 results ahead of estimates; Mgmt raises guidance for the full year; We…
  • 01/03/12 Morning Note B. Riley & Co. Morning Notes: AXTI, BC, BEBE, CSTR, DRL, GSM, JMBA, KEYN, KTOS, LIOX, MYGN, TWO, WWWW, Exhibitor Industry
  • 01/03/12 Update B. Riley & Co Focus List for the Month of January: AXTI, BC, BEBE, CSTR, DRL, GSM, JMBA, KTOS, LIOX, MYGN, TWO, WWWW
  • 12/01/11 Update B. Riley & Co. Focus List for the Month of December: BC, CSTR, DRL, DRCO, GSM, HOTT, JMBA, LIOX, MYGN, OPLK, TWO, WWWW
  • 11/02/11 Morning Note B. Riley & Co. Morning Notes: AGNC, BIRT, DENN, DRCO, GHDX, JDSU, KTOS, MSPD, MYGN, OPXT, SHOO, SIMO, TXRH, UEIC, UNTD, VCLK, YHOO
  • 11/02/11 Update MYGN (Buy; $32.00): Strong Fiscal Q1 leads to top and bottom line beat; Sets the tone for strong year and we are taking up estimates as a result.…
  • 11/01/11 Morning Note B. Riley & Co. Morning Notes: ANH, AOL, BBRG, BJRI, BMTC, CIDM, COHR, CVU, DRCO, Focus List, GHDX, GPX, JDSU, LIOX, MSPD, MYGN, NARA, OPXT, Q3 '11…
  • 11/01/11 Update B. Riley & Co. Focus List for the Month of November: AGNC, BC, CHRS, CSTR, DRL, DRCO, GSM, IBKC, JMBA, LIOX, MYGN, OPLK, WWWW
  • 10/05/11 Morning Note B. Riley & Co. Morning Notes: ACW, BEBE, CALD, GHDX, MSPD, Molecular Diagnostic Industry, MYGN, NEWP, VRML, WTSLA, ZUMZ
  • 10/04/11 Initiation of Coverage B. Riley & Co. Industry Initiation: A Secular Change in Disease Management Now Ripe for Investment - Initiating Coverage of Molecular Diagnostic Companies:…
  • 10/04/11 Initiation of Coverage MYGN (Buy; $32.00): In controversy an opportunity arises; initiating coverage with a Buy rating and a $32 price target